SSI Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,164
| Closed | -$242K | – | 263 |
|
|
2025
Q1 | $242K | Buy |
+2,164
| New | +$223K | 0.02% | 242 |
|
|
2023
Q2 | – | Sell |
-2,529
| Closed | -$210K | – | 252 |
|
|
2023
Q1 | $210K | Sell |
2,529
-460
| -15% | -$38.1K | 0.01% | 250 |
|
|
2022
Q4 | $257K | Buy |
+2,989
| New | +$237K | 0.02% | 275 |
|
|
2022
Q1 | – | Sell |
-3,024
| Closed | -$219K | – | 320 |
|
|
2021
Q4 | $219K | Sell |
3,024
-10
| -0.3% | -$689 | 0.01% | 306 |
|
|
2021
Q3 | $211K | Hold |
3,034
| – | – | 0.01% | 298 |
|
|
2021
Q2 | $209K | Buy |
+3,034
| New | +$203K | 0.01% | 310 |
|
|
2020
Q3 | – | Sell |
-3,130
| Closed | -$240K | – | 263 |
|
|
2020
Q2 | $240K | Sell |
3,130
-58
| -2% | -$4.45K | 0.02% | 232 |
|
|
2020
Q1 | $237K | Sell |
3,188
-43
| -1% | -$2.97K | 0.02% | 226 |
|
|
2019
Q4 | $207K | Sell |
3,231
-12
| -0.4% | -$781 | 0.01% | 277 |
|
|
2019
Q3 | $206K | Sell |
3,243
-3
| -0.1% | -$196 | 0.02% | 276 |
|
|
2019
Q2 | $219K | Sell |
3,246
-18
| -0.6% | -$1.18K | 0.02% | 270 |
|
|
2019
Q1 | $211K | Sell |
3,264
-11
| -0.3% | -$731 | 0.02% | 260 |
|
|
2018
Q4 | $204K | Sell |
3,275
-14
| -0.4% | -$979 | 0.02% | 249 |
|
|
2018
Q3 | $250K | Sell |
3,289
-18
| -0.5% | -$1.36K | 0.02% | 269 |
|
|
2018
Q2 | $234K | Sell |
3,307
-446
| -12% | -$31.5K | 0.02% | 263 |
|
|
2018
Q1 | $283K | Sell |
3,753
-62
| -2% | -$4.93K | 0.02% | 263 |
|
|
2017
Q4 | $274K | Sell |
3,815
-5
| -0.1% | -$380 | 0.02% | 270 |
|
|
2017
Q3 | $312K | Sell |
3,820
-27
| -0.7% | -$2.06K | 0.03% | 266 |
|
|
2017
Q2 | $272K | Sell |
3,847
-51
| -1% | -$3.39K | 0.02% | 275 |
|
|
2017
Q1 | $263K | Sell |
3,898
-6
| -0.2% | -$422 | 0.02% | 269 |
|
|
2016
Q4 | $279K | Sell |
3,904
-7
| -0.2% | -$520 | 0.03% | 252 |
|
|
2016
Q3 | $309K | Sell |
3,911
-42
| -1% | -$3.41K | 0.03% | 241 |
|
|
2016
Q2 | $329K | Buy |
3,953
+79
| +2% | +$7.01K | 0.03% | 222 |
|
|
2016
Q1 | $358K | Sell |
3,874
-1
| -0% | -$90 | 0.04% | 207 |
|
|
2015
Q4 | $393K | Hold |
3,875
| – | – | 0.04% | 202 |
|
|
2015
Q3 | $381K | Hold |
3,875
| – | – | 0.04% | 202 |
|
|
2015
Q2 | $454K | Sell |
3,875
-330
| -8% | -$36.1K | 0.04% | 203 |
|
|
2015
Q1 | $413K | Sell |
4,205
-1,597
| -28% | -$162K | 0.04% | 218 |
|
|
2014
Q4 | $550K | Buy |
5,802
+230
| +4% | +$23.8K | 0.06% | 212 |
|
|
2014
Q3 | $594K | Buy |
5,572
+1,685
| +43% | +$165K | 0.06% | 204 |
|
|
2014
Q2 | $322K | Sell |
3,887
-73
| -2% | -$5.68K | 0.03% | 302 |
|
|
2014
Q1 | $281K | Sell |
3,960
-18,481
| -82% | -$1.45M | 0.03% | 332 |
|
|
2013
Q4 | $1.69M | Buy |
22,441
+5,603
| +33% | +$390K | 0.15% | 159 |
|
|
2013
Q3 | $1.06M | Sell |
16,838
-115
| -0.7% | -$6.87K | 0.1% | 203 |
|
|
2013
Q2 | $871K | Buy |
+16,953
| New | +$884K | 0.09% | 225 |
|
Other funds holding GILD
SSI Investment Management's GILD Position: Q2 2025 in Review
SSI Investment Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 2,164 shares — an estimated $242K sold.
SSI Investment Management first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $1.69M in Q4 2013. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- SSI Investment Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- SSI Investment Management sold 2,164 Gilead Sciences shares in Q2 2025, an estimated $242K.
- SSI Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- SSI Investment Management's Gilead Sciences position peaked at $1.69M in Q4 2013.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on SSI Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.